Yoichiro Yamana
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
COVID-19 After Treatment With Direct-acting Antivirals for HCV Infection and Decompensated Cirrhosis: A Case Report.
Journal: In vivo (Athens, Greece)
Published: March 20, 2022
Left Gastric Vein Width Is an Important Risk Factor for Exacerbation of Esophageal Varices Post Balloon-Occluded Retrograde Transvenous Obliteration for Gastric Varices in Cirrhotic Patients.
Journal: Medicina (Kaunas, Lithuania)
Published: December 04, 2021
Efficacy of Glecaprevir/Pibrentasvir for Real-World HCV Infected Patients in the Northern Part of Tokyo, Japan.
Journal: Journal of clinical medicine
Published: November 09, 2021
Japanese Man with HCV Genotype 4 Infection and Cirrhosis Who Was Successfully Treated by the Combination of Glecaprevir and Pibrentasvir.
Journal: Internal medicine (Tokyo, Japan)
Published: February 01, 2021
Occurrence of hepatitis in an elderly woman during the treatment of pembrolizumab for right advanced renal pelvis, ureteral cancer, and bladder cancer.
Journal: JGH open : an open access journal of gastroenterology and hepatology
Published: January 11, 2021
Portal-systemic Encephalopathy due to Complicated Spleno-renal Shunt Successfully Treated with Balloon-occluded Retrograde Transvenous Obliteration Using a Double Coaxial Balloon Catheter System and Shape-memory Coils.
Journal: Internal medicine (Tokyo, Japan)
Published: March 02, 2018
Ventricular Tachycardia as a Complication of Ledipasvir and Sofosbuvir Treatment for HCV Infection.
Journal: Internal medicine (Tokyo, Japan)
Published: April 07, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026